A Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents
NCT07348666 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-08-12
Summary
Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death amongst youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to increase engagement with effective interventions such as suicide safety planning. The BRITE suicide safety planning app was developed on evidence-based principles and has undergone rigorous formative development and effectiveness evaluations. However, to optimize its functionality, commercial viability, and scale its implementation, issues related to user engagement needed to be addressed. This 3 month Pragmatic Randomized Trial will evaluate the impact of the ViraSafe app-an enhanced version of the BRITE suicide safety planning app-on improving engagement with coping skills and safety planning among suicidal adolescents by comparing its intervention components to those of the original BRITE app.
Conditions
- Suicide
- Mental Health Disorder
- Anhedonia
Interventions
- BEHAVIORAL
-
ViraSafe: Treatment pushes
ViraSafe participants will complete a safety plan with their provider. Safety plan content will be editable and viewable throughout the intervention for both participants and their providers. Participants will be able to access the safety plan at any time in ViraSafe. Additionally, patients using ViraSafe will be prompted to complete a daily distress rating. ViraSafe uses automated algorithms (i.e., just in time adaptive intervention features) and user input from distress ratings to facilitate increased engagement with coping skills and pushes safety planning materials to users at periods of high risk (i.e., increases in emotional distress). In addition to the just-in-time reminders (i.e., nudges) pushed automatically by the system, through the Vira Pro platform, practitioners can schedule just-in-time reminders (i.e., "nudges") to arrive in the user's phone to support their behavior change plan.
- BEHAVIORAL
-
BRITE
The BRITE app contains the teen's safety plan, links to videos of how to use coping strategies they indicated in their safety plan that have been useful for them (like guided mediation or deep breathing), a library of evidence-based and age-appropriate coping skills and strategies that the adolescent can learn more about, photos or videos that the adolescent has uploaded to the app, and includes a question asking them to rate their distress level in the moment: "What is your distress level right now?" (1 is "Least Distressed" to 5, which is "Most Distressed"). Then, the teen is asked to identify the feeling that fits their distress level via 12 emoji images: "Which feelings fit your distress level?" Based on adolescent's distress rate, the BRITE app suggests coping skills or "activities" for the adolescent to lower their distress level.
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH -
University of Pittsburgh Medical Center
collaborator OTHER -
Ksana Health
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 13 Years
- Max Age
- 24 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-18
- Primary Completion
- 2027-12-01
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
NCT05786066 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Ketamine in the Acute Phase of Suicidal Ideation
NCT02299440 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
NCT07065240 ·Status: RECRUITING ·Phase: PHASE2
-
Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder
NCT01667926 ·Status: COMPLETED ·Phase: NA
-
Sustained Ketamine Effectiveness for Suicidal Ideation
NCT06806475 ·Status: COMPLETED
-
A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)
NCT03149991 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Bupropion on Seizure Threshold in Depressed Patients
NCT03126682 ·Status: COMPLETED ·Phase: PHASE4
-
Using a Low Dose of Ketamine vs. Active Placebo in Treating Severe Depression and Suicide
NCT03666390 ·Status: UNKNOWN ·Phase: NA
-
An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)
NCT07161700 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression
NCT07247006 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Suicide Prevention by Lithium - the Lithium Intervention Study
NCT00520026 ·Status: TERMINATED ·Phase: NA
-
Treatment of Suicidal Ideation With Intravenous Ketamine Infusion
NCT01887990 ·Status: COMPLETED ·Phase: NA
-
Vortioxetine for the Treatment of Major Depression and Co-morbidities After Traumatic Brain Injury (TBI)
NCT02845349 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder
NCT06058039 ·Status: COMPLETED ·Phase: PHASE3
-
Intranasal Ketamine for Suicidal Ideation in Veterans
NCT03788694 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
NCT03065335 ·Status: RECRUITING ·Phase: PHASE1
-
Ketamine + Cognitive Training for Suicidality in the Medical Setting
NCT04578938 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Lethargic Depression Study
NCT00064467 ·Status: COMPLETED ·Phase: PHASE3
-
Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive Disorder
NCT01733654 ·Status: WITHDRAWN ·Phase: PHASE2
-
Real-life Effectiveness of Vortioxetine in Depression
NCT03555136 ·Status: COMPLETED
-
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
NCT06058013 ·Status: COMPLETED ·Phase: PHASE3
-
Intranasal Ketamine for Late-Life Depression and Suicidal Ideation
NCT02295787 ·Status: WITHDRAWN ·Phase: PHASE4
-
Psilocybin for Treatment-Resistant Depression
NCT05029466 ·Status: COMPLETED ·Phase: PHASE2
-
A Single Ketamine Infusion Combined With Music for Suicidal Ideation
NCT04658420 ·Status: UNKNOWN ·Phase: PHASE2
-
A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide
NCT02133001 ·Status: COMPLETED ·Phase: PHASE2